|
|
|||||
|
|
|
||||
|
May 2008
A short while ago, my daughter forwarded to me a posting on my granddaughters school website titled U.S. death toll associated with human papillomavirus vaccine jumps to 11, 3,779 adverse reactions reported. It goes on to say, The adverse reports coming from the HPV vaccine are increasing daily at an alarming rate. It is interesting to examine the facts and also the identity of the people posting this message. Parenthetically, their response to my reply was that I was not entitled to post listings on their listserv, as I did not have a child in the school. They rejected the fact that I could provide some factual information and that I was a grandparent of one of the students. They did not, however, contest any of the information in my posting. These pernicious messages are difficult to contest, as we often are not aware of the content of the listservs of our patients schools. It is important that when we do become aware, that we take the time to respond. Presumably the data on this listserv was gleaned from Vaccine Adverse Event Reporting System (VAERS) data. On the VAERS website (http://vaers.hhs.gov/info.htm) it is clearly stated that in some media reports and on some websites on the internet, VAERS reports are presented as verified cases of vaccine deaths and injuries. Statements such as these misrepresent the nature of the VAERS surveillance system. VAERS officials go on to state on their website, When evaluating data from VAERS, it is important to note that for any reported event, no cause and effect relationship has been established. VAERS is interested in all potential associations between vaccines and adverse events. Therefore, VAERS collects data on any adverse event following vaccination, be it coincidental or truly caused by a vaccine. The report of an adverse event to VAERS is not documentation that a vaccine caused the event. The data on adverse events associated with the HPV vaccine are not a secret. They appear in the Advisory Committee on Immunization Practices statement on HPV vaccine (MMWR. 2007; 56(RR02);1-24) and in the package insert. In these reports, they are presented in comparison with a placebo group so one can discern what is attributable to the vaccine; ie, the difference between the two groups. There is a very slight increase in injection site reactions or slight temperature elevations. There were essentially the same number of deaths in the two groups. In contrast, the data cited on the listserv show no comparison group. The VAERS reports encourage individuals to report events temporally associated with immunization. It is designed to detect major trends that may suggest problems with vaccines; eg, intussusception and rotavirus vaccine. These are events anyone can report by calling 1-800-822-7967. In the posting on the listserv, they refer to 11 deaths reported to VAERS out of approximately 13 millions doses of vaccine. In the years before the vaccine was released, there were approximately 20 deaths daily in this age group. Two of the 11 deaths were cited on the basis of secondhand information; ie, someone told someone else. Two additional cases were reported after someone heard about them at a conference. In examining these reports, I find no consistent pattern to explain the deaths. Many cases were remote from the vaccination; one, an anaphylactic reaction that occurred three days later. Two cases were due to thrombotic episodes in contraceptive takers. One had multiple organ failure secondary to influenza B and staph sepsis. In some, there were autopsies that revealed nothing remarkable. I am unimpressed that any of these deaths were due to the vaccine, but investigation of some of the cases is continuing. They include 13 cases of Guillian-Barre Syndrome temporally associated with the vaccine, which frequently was given at the same time as meningococcal vaccine and is well below the expected baseline number of cases.
|
![]()